ERFL
gene geneOn this page
Also known as erfl1
Summary
ERFL (ETS repressor factor like, HGNC:53894) is a protein-coding gene on chromosome 19q13.2, encoding ETS domain-containing transcription factor ERF-like (A0A1W2PQ73).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific. Predicted to be involved in cell differentiation and regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 390937 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001365103
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53894 |
| Approved symbol | ERFL |
| Name | ETS repressor factor like |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | erfl1 |
| Ensembl gene | ENSG00000268041 |
| Ensembl biotype | protein_coding |
| Entrez | 390937 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000597630
RefSeq mRNA: 1 — MANE Select: NM_001365103
NM_001365103
CCDS: CCDS92627
Canonical transcript exons
ENST00000597630 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002981349 | 41909060 | 41909177 |
| ENSE00003021310 | 41909276 | 41909471 |
| ENSE00003037174 | 41909863 | 41910097 |
| ENSE00003047080 | 41907704 | 41908676 |
| ENSE00003803196 | 41928040 | 41928449 |
| ENSE00003806480 | 41912853 | 41912932 |
Expression profiles
Bgee: expression breadth ubiquitous, 109 present calls, max score 72.21.
Top tissues by expression
120 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 72.21 | gold quality |
| sural nerve | UBERON:0015488 | 68.40 | gold quality |
| lymph node | UBERON:0000029 | 68.17 | gold quality |
| blood | UBERON:0000178 | 66.73 | gold quality |
| spleen | UBERON:0002106 | 66.36 | gold quality |
| bone marrow cell | CL:0002092 | 63.10 | silver quality |
| vermiform appendix | UBERON:0001154 | 61.97 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 61.58 | gold quality |
| cerebellum | UBERON:0002037 | 61.43 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 61.43 | gold quality |
| cerebellar cortex | UBERON:0002129 | 61.42 | gold quality |
| stromal cell of endometrium | CL:0002255 | 61.38 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 61.35 | gold quality |
| bone marrow | UBERON:0002371 | 61.22 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 60.82 | gold quality |
| colonic epithelium | UBERON:0000397 | 59.74 | gold quality |
| small intestine | UBERON:0002108 | 59.39 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 57.95 | gold quality |
| mucosa of stomach | UBERON:0001199 | 57.93 | gold quality |
| tonsil | UBERON:0002372 | 57.27 | gold quality |
| transverse colon | UBERON:0001157 | 56.80 | gold quality |
| ascending aorta | UBERON:0001496 | 55.51 | gold quality |
| gall bladder | UBERON:0002110 | 55.30 | gold quality |
| thoracic aorta | UBERON:0001515 | 55.25 | gold quality |
| right ovary | UBERON:0002118 | 54.68 | gold quality |
| left ovary | UBERON:0002119 | 53.56 | gold quality |
| intestine | UBERON:0000160 | 53.28 | gold quality |
| tibial artery | UBERON:0007610 | 53.18 | gold quality |
| popliteal artery | UBERON:0002250 | 53.14 | gold quality |
| uterine cervix | UBERON:0000002 | 53.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.61 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-265g22.4 | ENSDARG00000076512 |
| mus_musculus | Erfl | ENSMUSG00000108367 |
| rattus_norvegicus | Erfl | ENSRNOG00000068986 |
Paralogs (28): ETV1 (ENSG00000006468), ETV7 (ENSG00000010030), SPI1 (ENSG00000066336), ELF4 (ENSG00000102034), ETV2 (ENSG00000105672), ERF (ENSG00000105722), ELF2 (ENSG00000109381), ELK3 (ENSG00000111145), ETV3 (ENSG00000117036), ELF1 (ENSG00000120690), SPDEF (ENSG00000124664), ELK1 (ENSG00000126767), ETS1 (ENSG00000134954), EHF (ENSG00000135373), ELF5 (ENSG00000135374), ETV6 (ENSG00000139083), FLI1 (ENSG00000151702), GABPA (ENSG00000154727), ERG (ENSG00000157554), ETS2 (ENSG00000157557), ELK4 (ENSG00000158711), ELF3 (ENSG00000163435), FEV (ENSG00000163497), SPIC (ENSG00000166211), ETV4 (ENSG00000175832), ETV5 (ENSG00000244405), ETV3L (ENSG00000253831), SPIB (ENSG00000269404)
Protein
Protein identifiers
ETS domain-containing transcription factor ERF-like — A0A1W2PQ73 (reviewed: A0A1W2PQ73)
Alternative names: ETS repressor factor-like
All UniProt accessions (1): A0A1W2PQ73
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Similarity. Belongs to the ETS family.
RefSeq proteins (1): NP_001352032* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000418 | Ets_dom | Domain |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
| IPR046328 | ETS_fam | Family |
Pfam: PF00178
UniProt features (4 total): chain 1, DNA-binding region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1W2PQ73-F1 | 59.64 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX5_TARGET_GENES, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, chr19q13
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), cell differentiation (GO:0030154), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (4): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 1 |
| cellular developmental process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
112 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ERFL | RBM42 | Q9BTD8 | 447 |
| ERFL | HBS1L | Q9Y450 | 447 |
| ERFL | GSPT2 | Q8IYD1 | 400 |
| ERFL | RNF14 | Q9UBS8 | 327 |
| ERFL | GSPT1 | P15170 | 305 |
| ERFL | ERICH5 | Q6P6B1 | 301 |
| ERFL | SP5 | Q6BEB4 | 276 |
| ERFL | DNAJC12 | Q9UKB3 | 251 |
| ERFL | HSPB3 | Q12988 | 251 |
| ERFL | DOHH | Q9BU89 | 247 |
| ERFL | PLIN5 | Q00G26 | 228 |
| ERFL | UPF1 | Q92900 | 222 |
| ERFL | CABP1 | Q9NZU7 | 214 |
| ERFL | KCNS2 | Q9ULS6 | 212 |
| ERFL | ING2 | Q9H160 | 199 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1W2PQ73, A1YF16, A1YG93, A2RU54, A5PKG8, O02786, O14813, O15353, O35602, O43638, O57601, P13297, P19419, P28360, P35548, P41969, P42580, P43687, P49640, P50223, P50548, P52946, P52950, P63156, P63157, P70459, P78413, Q03358, Q14549, Q2VL78, Q2VL79, Q2VL82, Q2VL83, Q2VL84, Q2VL85, Q2VL86, Q2VL87, Q2VL88, Q5NSW5, Q61575
Diamond homologs: A0A1W2PQ73, A0JN51, A1A4L6, A1YF15, A1YG61, A1YG91, A2D4Z7, A2T737, A2T762, A3FEM2, A4GTP4, A8WFJ9, O00321, O01519, O70132, O70273, O95238, P01105, P10157, P11308, P11536, P13474, P14921, P15036, P15037, P15062, P18755, P18756, P19102, P19419, P20105, P26323, P27577, P28322, P28324, P29773, P29774, P29775, P29776, P32519
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2255 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:41909406:A:G | F123S | 1.000 |
| 19:41909408:G:C | N122K | 1.000 |
| 19:41909408:G:T | N122K | 1.000 |
| 19:41909411:G:C | F121L | 1.000 |
| 19:41909411:G:T | F121L | 1.000 |
| 19:41909412:A:C | F121C | 1.000 |
| 19:41909412:A:G | F121S | 1.000 |
| 19:41909413:A:C | F121V | 1.000 |
| 19:41909413:A:G | F121L | 1.000 |
| 19:41909413:A:T | F121I | 1.000 |
| 19:41909414:C:A | K120N | 1.000 |
| 19:41909414:C:G | K120N | 1.000 |
| 19:41909418:T:C | Y119C | 1.000 |
| 19:41909418:T:G | Y119S | 1.000 |
| 19:41909419:A:C | Y119D | 1.000 |
| 19:41909419:A:G | Y119H | 1.000 |
| 19:41909419:A:T | Y119N | 1.000 |
| 19:41909423:G:C | F117L | 1.000 |
| 19:41909423:G:T | F117L | 1.000 |
| 19:41909424:A:C | F117C | 1.000 |
| 19:41909424:A:G | F117S | 1.000 |
| 19:41909425:A:C | F117V | 1.000 |
| 19:41909425:A:G | F117L | 1.000 |
| 19:41909425:A:T | F117I | 1.000 |
| 19:41909426:C:A | R116S | 1.000 |
| 19:41909426:C:G | R116S | 1.000 |
| 19:41909427:C:A | R116M | 1.000 |
| 19:41909427:C:G | R116T | 1.000 |
| 19:41909428:T:A | R116W | 1.000 |
| 19:41909428:T:C | R116G | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000076635 (19:41917743 G>A), RS1000236192 (19:41926648 G>A,C), RS1000568600 (19:41925174 C>A,T), RS1001115757 (19:41919329 T>C), RS1001188354 (19:41927692 C>T), RS1001220874 (19:41927983 T>C,G), RS1002178666 (19:41916053 T>A,C), RS1002206079 (19:41916264 A>G), RS1002491757 (19:41907562 T>G), RS1002765191 (19:41910876 C>G,T), RS1002849705 (19:41918615 C>G,T), RS1002880753 (19:41918994 C>T), RS1002998952 (19:41912983 A>G), RS1003046556 (19:41907333 C>G,T), RS1003441960 (19:41913157 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sotorasib | affects cotreatment, decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| Thiram | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.